Andre Terzic

Prof. Dr. Andre Terzic


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in Cell Metabolism
Verified
Journal Article
Closed access
CFClifford Folmes
Clifford Folmes
TNTimothy J. Nelson
Timothy J. Nelson
AMAlmudena Martinez-Fernandez
Almudena Martinez-Fernandez
DAD. Kent Arrell
D. Kent Arrell
JLJelena Zlatkovic Lindor
Jelena Zlatkovic Lindor
ATAndre Terzic
Andre Terzic

1 November 2012 in Cell Stem Cell
Verified
Journal Article
Closed access
CFClifford Folmes
Clifford Folmes
PDPetras P. Dzeja
Petras P. Dzeja
TNTimothy J. Nelson
Timothy J. Nelson
ATAndre Terzic
Andre Terzic

1 February 2007 in Nature Clinical Practice Cardiovascular Medicine
Verified
Journal Article
Closed access
PDF file
SCSusan Chung
Susan Chung
PDPetras P Dzeja
Petras P Dzeja
RFRandolph S Faustino
Randolph S Faustino
CPCarmen Perez-Terzic
Carmen Perez-Terzic
ABAtta Behfar
Atta Behfar
ATAndre Terzic
Andre Terzic

Verified
Journal Article
Open access
PDF file
Petras DzejaPetras Dzeja
Petras Dzeja
ATAndre Terzic
Andre Terzic
Adenylate kinase and downstream AMP signaling is an integrated metabolic monitoring system which reads the cellular energy state in order to tune and report signals to metabolic sensors. A network of adenylate kinase isoforms (AK1-AK7) are distributed throughout intracellular compartments, interstitial space and body fluids to regulate energetic and metabolic signaling circuits, securing efficient cell energy economy, signal communication and stress response. The dynamics of adenylate kinase-catalyzed phosphotransfer regulates multiple intracellular and extracellular energy-dependent and nucleotide signaling processes, including excitation-contraction coupling, hormone secretion, cell and ciliary motility, nuclear transport, energetics of cell cycle, DNA synthesis and repair, and developmental programming. Metabolomic analyses indicate that cellular, interstitial and blood AMP levels are potential metabolic signals associated with vital functions including body energy sensing, sleep, hibernation and food intake. Either low or excess AMP signaling has been linked to human disease such as diabetes, obesity and hypertrophic cardiomyopathy. Recent studies indicate that derangements in adenylate kinase-mediated energetic signaling due to mutations in AK1, AK2 or AK7 isoforms are associated with hemolytic anemia, reticular dysgenesis and ciliary dyskinesia. Moreover, hormonal, food and antidiabetic drug actions are frequently coupled to alterations of cellular AMP levels and associated signaling. Thus, by monitoring energy state and generating and distributing AMP metabolic signals adenylate kinase represents a unique hub within the cellular homeostatic network.

13 June 2006 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
TOTimothy M. Olson
Timothy M. Olson
AAAlexey E. Alekseev
Alexey E. Alekseev
XLXiaoke K. Liu
Xiaoke K. Liu
SPSungjo Park
Sungjo Park
LZLeonid Zingman
Leonid Zingman
ATAndre Terzic
Andre Terzic
Atrial fibrillation is a rhythm disorder characterized by chaotic electrical activity of cardiac atria. Predisposing to stroke and heart failure, this common condition is increasingly recognized as a heritable disorder. To identify genetic defects conferring disease susceptibility, patients with idiopathic atrial fibrillation, lacking traditional risk factors, were evaluated. Genomic DNA scanning revealed a nonsense mutation in KCNA5 that encodes Kv1.5, a voltage-gated potassium channel expressed in human atria. The heterozygous E375X mutation, present in a familial case of atrial fibrillation and absent in 540 unrelated control individuals, introduced a premature stop codon disrupting the Kv1.5 channel protein. The truncation eliminated the S4–S6 voltage sensor, pore region and C-terminus, preserving the N-terminus and S1–S3 transmembrane domains that secure tetrameric subunit assembly. Heterologously expressed recombinant E375X mutant failed to generate the ultrarapid delayed rectifier current IKur vital for atrial repolarization and exerted a dominant-negative effect on wild-type current. Loss of channel function translated into action potential prolongation and early after-depolarization in human atrial myocytes, increasing vulnerability to stress-provoked triggered activity. The pathogenic link between compromised Kv1.5 function and susceptibility to atrial fibrillation was verified, at the organism level, in a murine model. Rescue of the genetic defect was achieved by aminoglycoside-induced translational read-through of the E375X premature stop codon, restoring channel function. This first report of Kv1.5 loss-of-function channelopathy establishes KCNA5 mutation as a novel risk factor for repolarization deficiency and atrial fibrillation.

4 August 2009 in Circulation
Verified
Journal Article
Closed access
PDF file
TNTimothy J. Nelson
Timothy J. Nelson
AMAlmudena Martinez-Fernandez
Almudena Martinez-Fernandez
SYSatsuki Yamada
Satsuki Yamada
CPCarmen Perez-Terzic
Carmen Perez-Terzic
YIYasuhiro Ikeda
Yasuhiro Ikeda
ATAndre Terzic
Andre Terzic
Background— Nuclear reprogramming provides an emerging strategy to produce embryo-independent pluripotent stem cells from somatic tissue. Induced pluripotent stem cells (iPS) demonstrate aptitude for de novo cardiac differentiation, yet their potential for heart disease therapy has not been tested. Methods and Results— In this study, fibroblasts transduced with human stemness factors OCT3/4, SOX2, KLF4, and c-MYC converted into an embryonic stem cell–like phenotype and demonstrated the ability to spontaneously assimilate into preimplantation host morula via diploid aggregation, unique to bona fide pluripotent cells. In utero, iPS-derived chimera executed differentiation programs to construct normal heart parenchyma patterning. Within infarcted hearts in the adult, intramyocardial delivery of iPS yielded progeny that properly engrafted without disrupting cytoarchitecture in immunocompetent recipients. In contrast to parental nonreparative fibroblasts, iPS treatment restored postischemic contractile performance, ventricular wall thickness, and electric stability while achieving in situ regeneration of cardiac, smooth muscle, and endothelial tissue. Conclusions— Fibroblasts reprogrammed by human stemness factors thus acquire the potential to repair acute myocardial infarction, establishing iPS in the treatment of heart disease.